Argentine Hemorrhagic Fever (AHF) is a severe viral illness caused by the Junin virus, a member of the Arenaviridae family. This disease is endemic to certain regions of Argentina, particularly the Pampas and Gran Chaco regions, where the natural reservoir is the corn mouse (Calomys musculinus). The primary mode of transmission to humans occurs through inhalation of aerosolized particles contaminated with the virus, often derived from rodent excreta. AHF typically presents with an initial febrile phase, followed by more severe symptoms such as hemorrhagic manifestations, neurological complications, and multi-organ failure. The clinical spectrum of AHF can range from mild cases with flu-like symptoms to severe cases characterized by bleeding, shock, and high mortality rates. Early diagnosis is crucial for patient outcomes, and ribavirin, an antiviral medication, has shown efficacy in treating AHF if administered during the early stages of the disease. Vector control measures and public health interventions play a vital role in preventing the spread of Junin virus, emphasizing the importance of community awareness and surveillance programs in affected regions.